Tumor DNA was extracted from these samples, and pyrosequencing analysis revealed that 5 CpG regions of the MGMT promoter were intermediate methylated (Figure 5(b)), which could be indicated by the average percentage of methylated CpG site in the mean range of 10–26%. The gene discussed is MGMT; the disease is neoplasm.